Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Patients' Views About Skin Self-examination After Treatment for Localized Melanoma.

Dieng M, Smit AK, Hersch J, Morton RL, Cust AE, Irwig L, Low D, Low C, Bell KJL.

JAMA Dermatol. 2019 May 15. doi: 10.1001/jamadermatol.2019.0434. [Epub ahead of print]

PMID:
31090868
2.

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.

Nayak A, Hayen A, Zhu L, McGeechan K, Glasziou P, Irwig L, Doust J, Gregory G, Bell K.

BMJ Open. 2018 Oct 4;8(9):e020584. doi: 10.1136/bmjopen-2017-020584.

3.

Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma.

Lim WY, Turner RM, Morton RL, Jenkins MC, Irwig L, Webster AC, Dieng M, Saw RPM, Guitera P, Low D, Low C, Bell KJL.

BMC Health Serv Res. 2018 Jun 20;18(1):477. doi: 10.1186/s12913-018-3291-7.

4.

Prognostic impact of systolic blood pressure variability in people with diabetes.

Bell KJL, Azizi L, Nilsson PM, Hayen A, Irwig L, Östgren CJ, Sundröm J.

PLoS One. 2018 Apr 11;13(4):e0194084. doi: 10.1371/journal.pone.0194084. eCollection 2018.

5.

Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.

Lim WY, Morton RL, Turner RM, Jenkins MC, Guitera P, Irwig L, Webster AC, Dieng M, Saw RPM, Low D, Low C, Bell KJL.

JAMA Dermatol. 2018 Apr 1;154(4):420-427. doi: 10.1001/jamadermatol.2018.0021.

6.

Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?

Bonner C, Bell K, Jansen J, Glasziou P, Irwig L, Doust J, McCaffery K.

BMC Cardiovasc Disord. 2018 Feb 7;18(1):19. doi: 10.1186/s12872-018-0760-1.

7.

How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.

Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, Houssami N, Dhillon H, McCaffery K.

BMJ Open. 2017 Oct 6;7(10):e016246. doi: 10.1136/bmjopen-2017-016246.

8.

Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year.

Jacklyn G, Morrell S, McGeechan K, Houssami N, Irwig L, Pathmanathan N, Barratt A.

Breast. 2018 Feb;37:170-178. doi: 10.1016/j.breast.2017.08.005. Epub 2017 Sep 5.

PMID:
28882419
9.

Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.

Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, Barratt A.

Breast Cancer Res Treat. 2017 Dec;166(3):843-854. doi: 10.1007/s10549-017-4443-x. Epub 2017 Aug 19.

PMID:
28822001
10.

Impact of extending screening mammography to older women: Information to support informed choices.

Jacklyn G, Howard K, Irwig L, Houssami N, Hersch J, Barratt A.

Int J Cancer. 2017 Oct 15;141(8):1540-1550. doi: 10.1002/ijc.30858. Epub 2017 Jul 10. Erratum in: Int J Cancer. 2017 Dec 15;141(12 ):E8.

11.

Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice.

Walter SD, Turner RM, Macaskill P, McCaffery KJ, Irwig L.

BMC Med Res Methodol. 2017 Feb 20;17(1):29. doi: 10.1186/s12874-017-0304-x.

12.

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HC, Bossuyt PM.

BMJ Open. 2016 Nov 14;6(11):e012799. doi: 10.1136/bmjopen-2016-012799.

13.

Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect.

Bell KJ, Hayen A, Glasziou P, Irwig L, Bauer DC.

Ann Intern Med. 2017 Jan 17;166(2):152. doi: 10.7326/L16-0528. No abstract available.

PMID:
28114470
14.

General Practitioners' Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study.

Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, Bell K, Naganathan V, McCaffery K.

PLoS One. 2017 Jan 13;12(1):e0170228. doi: 10.1371/journal.pone.0170228. eCollection 2017.

15.

Fear of new or recurrent melanoma after treatment for localised melanoma.

Bell KJL, Mehta Y, Turner RM, Morton RL, Dieng M, Saw R, Guitera P, McCaffery K, Low D, Low C, Jenkins M, Irwig L, Webster AC.

Psychooncology. 2017 Nov;26(11):1784-1791. doi: 10.1002/pon.4366. Epub 2017 Feb 2.

PMID:
28052599
16.
17.

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, Houssami N.

Ann Surg Oncol. 2016 Nov;23(12):3811-3821. Epub 2016 Aug 15. Review.

18.

Factors influencing general practitioners' decisions about cardiovascular disease risk reassessment: findings from experimental and interview studies.

McKinn S, Bonner C, Jansen J, Teixeira-Pinto A, So M, Irwig L, Doust J, Glasziou P, McCaffery K.

BMC Fam Pract. 2016 Aug 5;17:107. doi: 10.1186/s12875-016-0499-7.

19.

Updating standards for reporting diagnostic accuracy: the development of STARD 2015.

Korevaar DA, Cohen JF, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Moher D, de Vet HCW, Altman DG, Hooft L, Bossuyt PMM.

Res Integr Peer Rev. 2016 Jun 7;1:7. doi: 10.1186/s41073-016-0014-7. eCollection 2016.

20.

Too much medicine in older people? Deprescribing through shared decision making.

Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, Bonner C, Doust J, Colvin J, Heaney A, Turner R, McCaffery K.

BMJ. 2016 Jun 3;353:i2893. doi: 10.1136/bmj.i2893. No abstract available.

PMID:
27260319
21.

Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data.

Bell KJ, Hayen A, Glasziou P, Irwig L, Eastell R, Harrison SL, Black DM, Bauer DC.

J Bone Miner Res. 2016 Sep;31(9):1767-73. doi: 10.1002/jbmr.2847. Epub 2016 Apr 25.

22.

Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

Perera R, McFadden E, McLellan J, Lung T, Clarke P, Pérez T, Fanshawe T, Dalton A, Farmer A, Glasziou P, Takahashi O, Stevens J, Irwig L, Hirst J, Stevens S, Leslie A, Ohde S, Deshpande G, Urayama K, Shine B, Stevens R.

Health Technol Assess. 2015 Dec;19(100):1-401, vii-viii. doi: 10.3310/hta191000. Review.

23.

The importance of enabling informed decision making for women considering breast cancer screening.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

J Med Screen. 2016 Mar;23(1):55. doi: 10.1177/0969141315612818. Epub 2015 Nov 17. No abstract available.

PMID:
26582494
24.

How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.

McCaffery K, Nickel B, Moynihan R, Hersch J, Teixeira-Pinto A, Irwig L, Barratt A.

BMJ Open. 2015 Nov 2;5(11):e008094. doi: 10.1136/bmjopen-2015-008094.

25.

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

BMJ. 2015 Oct 28;351:h5527. doi: 10.1136/bmj.h5527. No abstract available.

26.

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

Clin Chem. 2015 Dec;61(12):1446-52. doi: 10.1373/clinchem.2015.246280. Epub 2015 Oct 28.

27.

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF; STARD Group.

Radiology. 2015 Dec;277(3):826-32. doi: 10.1148/radiol.2015151516. Epub 2015 Oct 28.

PMID:
26509226
28.

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis.

Marinovich ML, Macaskill P, Irwig L, Sardanelli F, Mamounas E, von Minckwitz G, Guarneri V, Partridge SC, Wright FC, Choi JH, Bhattacharyya M, Martincich L, Yeh E, Londero V, Houssami N.

BMC Cancer. 2015 Oct 8;15:662. doi: 10.1186/s12885-015-1664-4.

29.

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

Nickel B, Barratt A, Hersch J, Moynihan R, Irwig L, McCaffery K.

Breast. 2015 Oct;24(5):673-9. doi: 10.1016/j.breast.2015.08.004. Epub 2015 Sep 12.

PMID:
26376460
30.

Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults.

Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, Nickel B, van Munster B, McCaffery K.

BMC Fam Pract. 2015 Aug 20;16:104. doi: 10.1186/s12875-015-0310-1. Review.

31.

Is the "Heart Age" Concept Helpful or Harmful Compared to Absolute Cardiovascular Disease Risk? An Experimental Study.

Bonner C, Jansen J, Newell BR, Irwig L, Teixeira-Pinto A, Glasziou P, Doust J, McKinn S, McCaffery K.

Med Decis Making. 2015 Nov;35(8):967-78. doi: 10.1177/0272989X15597224. Epub 2015 Aug 6.

PMID:
26251465
32.

How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?

Memari N, Hayen A, Bell KJ, Rychetnik L, Morton RL, McCaffery K, Thompson JF, Irwig L, Turner RM.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1164-71. doi: 10.1245/s10434-015-4589-x. Epub 2015 May 12.

PMID:
25963479
33.

Screening tests for gonorrhoea should first do no harm.

Bell K, McCaffery KJ, Irwig L.

Med J Aust. 2015 Apr 6;202(6):281-2. No abstract available.

PMID:
25832137
34.

Assessment of changes to screening programmes: why randomisation is important.

Bell KJ, Bossuyt P, Glasziou P, Irwig L.

BMJ. 2015 Mar 30;350:h1566. doi: 10.1136/bmj.h1566. No abstract available.

PMID:
25825377
35.

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, Thornton H, Dhillon H, Houssami N, McCaffery K.

Lancet. 2015 Apr 25;385(9978):1642-52. doi: 10.1016/S0140-6736(15)60123-4. Epub 2015 Feb 18. Erratum in: Lancet. 2015 Apr 25;385(9978):1622.

PMID:
25701273
36.

Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer.

Marinovich ML, Houssami N, Macaskill P, von Minckwitz G, Blohmer JU, Irwig L.

Int J Cancer. 2015 Jun 1;136(11):2730-7. doi: 10.1002/ijc.29323. Epub 2014 Nov 25.

37.

A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.

Barratt A, Irwig L, Glasziou P.

Int J Cancer. 2015 May 15;136(10):2486. doi: 10.1002/ijc.29270. Epub 2014 Nov 18. No abstract available.

38.

Red flags to screen for malignancy and fracture in patients with low back pain.

Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, Macaskill P, Irwig L, van Tulder MW, Koes BW, Maher CG.

Br J Sports Med. 2014 Oct;48(20):1518. doi: 10.1136/bjsports-2014-f7095rep.

PMID:
25257627
39.

Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.

Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, Thornton H, Dhillon H, McCaffery K.

BMJ Open. 2014 Sep 25;4(9):e006016. doi: 10.1136/bmjopen-2014-006016.

40.

Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data.

Bell KJ, Beller E, Sundström J, McGeechan K, Hayen A, Irwig L, Neal B, Glasziou P.

BMJ Open. 2014 Sep 8;4(9):e006044. doi: 10.1136/bmjopen-2014-006044.

41.

How do general practitioners and patients make decisions about cardiovascular disease risk?

Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, McCaffery K.

Health Psychol. 2015 Mar;34(3):253-61. doi: 10.1037/hea0000122. Epub 2014 Aug 18.

PMID:
25133842
42.

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.

McGeechan K, Macaskill P, Irwig L, Bossuyt PM.

BMC Med Res Methodol. 2014 Jul 3;14:86. doi: 10.1186/1471-2288-14-86.

43.

Communicating cardiovascular disease risk: an interview study of General Practitioners' use of absolute risk within tailored communication strategies.

Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, McCaffery K.

BMC Fam Pract. 2014 May 29;15:106. doi: 10.1186/1471-2296-15-106.

44.

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.

Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, Dhillon H, Thornton H, McGeechan K, Howard K, McCaffery K.

BMJ Open. 2014 May 15;4(5):e004990. doi: 10.1136/bmjopen-2014-004990.

45.

General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study.

Jansen J, Bonner C, McKinn S, Irwig L, Glasziou P, Doust J, Teixeira-Pinto A, Hayen A, Turner R, McCaffery K.

BMJ Open. 2014 May 15;4(5):e004812. doi: 10.1136/bmjopen-2014-004812.

46.

I don't believe it, but i'd better do something about it: patient experiences of online heart age risk calculators.

Bonner C, Jansen J, Newell BR, Irwig L, Glasziou P, Doust J, Dhillon H, McCaffery K.

J Med Internet Res. 2014 May 5;16(5):e120. doi: 10.2196/jmir.3190.

47.

Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects.

Turner RM, Walter SD, Macaskill P, McCaffery KJ, Irwig L.

Med Decis Making. 2014 Aug;34(6):711-9. doi: 10.1177/0272989X14525264. Epub 2014 Apr 2.

PMID:
24695962
48.

Which lipid measurement should we monitor? An analysis of the LIPID study.

Glasziou PP, Irwig L, Kirby AC, Tonkin AM, Simes RJ.

BMJ Open. 2014 Feb 21;4(2):e003512. doi: 10.1136/bmjopen-2013-003512.

49.

Red flags to screen for malignancy and fracture in patients with low back pain: systematic review.

Downie A, Williams CM, Henschke N, Hancock MJ, Ostelo RW, de Vet HC, Macaskill P, Irwig L, van Tulder MW, Koes BW, Maher CG.

BMJ. 2013 Dec 11;347:f7095. doi: 10.1136/bmj.f7095. Review. Erratum in: BMJ. 2014;348:g7.

50.

Criteria for monitoring tests were described: validity, responsiveness, detectability of long-term change, and practicality.

Bell KJ, Glasziou PP, Hayen A, Irwig L.

J Clin Epidemiol. 2014 Feb;67(2):152-9. doi: 10.1016/j.jclinepi.2013.07.015. Epub 2013 Nov 1.

PMID:
24189088

Supplemental Content

Loading ...
Support Center